ATI RN
Burns Pediatric Primary Care 7th Edition Test Bank Questions
Question 1 of 5
A healthy 20-day-old male examination reveals a palpable liver margin below the right costal margin; lab findings: white blood count, 18700/mm3; hemoglobin, 8.8 g/dl; blast cells, 10%; the BEST approach for the management is consistent with acute myeloproliferative disorder
Correct Answer: A
Rationale: The correct answer is A) intensive chemotherapy. In this scenario, the presence of blast cells in a 20-day-old infant is concerning for acute myeloproliferative disorder, a condition characterized by abnormal proliferation of myeloid cells in the bone marrow. Intensive chemotherapy is the recommended approach to rapidly reduce the blast cell population and prevent progression of the disease. Option B) low dose chemotherapy pulses may not be sufficient to effectively target and eliminate the blast cells in this aggressive disorder. Option C) bone marrow transplantation is typically considered in cases of refractory or relapsed disease, not as a first-line treatment in a newly diagnosed case. Option D) close follow up alone is not appropriate given the urgent need for intervention in acute myeloproliferative disorder. Educationally, understanding the appropriate management of pediatric hematologic disorders is crucial for healthcare providers working in primary care settings. Recognizing the signs and symptoms of acute myeloproliferative disorder and knowing the recommended treatment strategies can help ensure timely and effective care for pediatric patients with such conditions. This case highlights the importance of prompt diagnosis and initiation of appropriate therapy in pediatric hematology-oncology cases.
Question 2 of 5
Hepatoblastoma is a neoplasm of undifferentiated precursors of hepatocytes. It is of different histological classification; which type predict the MOST favorable outcome?
Correct Answer: B
Rationale: In pediatric oncology, understanding the histological classification of tumors like hepatoblastoma is crucial for prognosis and treatment planning. In this case, the correct answer is B) type of pure epithelial histology, which predicts the most favorable outcome. Hepatoblastoma with pure epithelial histology is associated with a more differentiated appearance, indicating a less aggressive tumor behavior and better response to treatment. This histological type often presents as well-differentiated fetal or embryonal cells, which are less likely to metastasize and have a higher chance of successful surgical resection. Option A) mixed type of pure epithelial and mesenchymal elements, and Option C) mixed fetal and embryonal histology, suggest a combination of cell types which can lead to a more heterogeneous and potentially aggressive tumor behavior, resulting in a less favorable prognosis. Option D) undifferentiated histology indicates a lack of cellular differentiation, which usually signifies a more aggressive and difficult to treat tumor. Tumors with undifferentiated histology often have a higher risk of metastasis and poorer outcomes compared to tumors with more differentiated histological features. Understanding these histological classifications in pediatric oncology not only aids in predicting outcomes but also guides healthcare providers in selecting the most appropriate treatment strategies for each patient. By recognizing the significance of histology in hepatoblastoma, healthcare professionals can optimize patient care and improve overall treatment outcomes.
Question 3 of 5
You are meeting with parents of a 10-year-old child who recently develops acute lymphoblastic leukemia (ALL). Which of the following is LEAST likely to increase the risk of CNS relapse in children with ALL?
Correct Answer: A
Rationale: In pediatric ALL, CNS relapse is a significant concern. The least likely factor to increase the risk of CNS relapse in children with ALL is the first traumatic lumbar puncture (LP), which is option A. This is because the initial LP is not associated with increased risk of CNS relapse. Option B, T-cell leukemia, is incorrect because T-cell ALL is associated with a higher risk of CNS relapse compared to B-cell ALL. Option C, cranial nerve involvement at diagnosis, is incorrect as it indicates the disease has already spread to the CNS, increasing the risk of relapse. Option D, the presence of lymphoblasts in the CSF, is also incorrect as it signifies CNS involvement and poses a higher risk of relapse. In an educational context, understanding the risk factors for CNS relapse in pediatric ALL is essential for healthcare providers managing these patients. It highlights the importance of monitoring and early intervention to prevent relapse and improve outcomes. Knowledge of these risk factors informs treatment decisions and close monitoring of patients to optimize their care.
Question 4 of 5
Childhood primary brain stem tumors are a heterogeneous group of tumors; the outcome usually depends on the tumor location. Which tumor, depending on the site of tumor, carries the worst prognosis?
Correct Answer: D
Rationale: In childhood primary brain stem tumors, the correct answer is D) diffuse intrinsic. This tumor carries the worst prognosis depending on its location. Diffuse intrinsic tumors are typically high-grade gliomas located within the brain stem, making them challenging to treat surgically due to their infiltrative nature. These tumors are associated with poor outcomes due to their aggressive growth patterns and proximity to vital structures in the brain stem, impacting neurological function significantly. Option A) focal dorsally exophytic and Option B) cervicomedullary diffuse intrinsic are not typically associated with the worst prognosis compared to diffuse intrinsic tumors. Focal dorsally exophytic tumors are usually more circumscribed and may be amenable to surgical resection, leading to a relatively better prognosis. Cervicomedullary diffuse intrinsic tumors, although challenging, are not as common as diffuse intrinsic tumors in the brain stem and may have a slightly better prognosis due to their location. In an educational context, understanding the prognosis of different types of childhood brain stem tumors is crucial for healthcare providers working in pediatric primary care. Recognizing the aggressive nature of diffuse intrinsic tumors and their impact on patient outcomes can guide healthcare professionals in providing appropriate support and treatment for affected children and their families. This knowledge can also help in making informed decisions regarding treatment options and setting realistic expectations with regards to prognosis and quality of life.
Question 5 of 5
Of the following, the WORST prognostic factor in pediatric osteosarcoma is
Correct Answer: B
Rationale: In pediatric osteosarcoma, the worst prognostic factor is a poor histologic response to treatment, which is option B. This is because the response to initial chemotherapy is a crucial predictor of outcome in osteosarcoma patients. A poor histologic response indicates resistance to treatment and is associated with higher rates of recurrence and poorer survival outcomes. Option A, primary pelvic bone tumor, is not as significant a prognostic factor as histologic response. While the location of the primary tumor can impact treatment approaches, it is not the most critical factor in determining prognosis. Option C, bony metastases at the time of diagnosis, while indicating advanced disease, can still be treated with aggressive therapy. In contrast, a poor histologic response suggests resistance to treatment regardless of the disease stage. Option D, lung metastases at the time of diagnosis, though serious, can still be managed with treatment. However, a poor histologic response directly reflects the tumor's biology and its ability to respond to therapy, making it a more critical prognostic factor. Educationally, understanding prognostic factors in pediatric osteosarcoma is vital for healthcare providers involved in the care of these patients. Recognizing the significance of a poor histologic response can guide treatment decisions and help set appropriate expectations for patient outcomes. It underscores the importance of monitoring treatment response and adjusting therapy accordingly to improve survival rates in pediatric osteosarcoma cases.